AFC-HD AMS Life Science Co., Ltd. Statistics
Want to see JP:2927 full AI Analyst Report?
AFC-HD AMS Life Science Co., Ltd. (2927) Stock Statistics & Valuation Metrics
Total Valuation
AFC-HD AMS Life Science Co., Ltd. has a market cap or net worth of JPY 11.99B. The enterprise value is JPY 26.59B.
- Market Cap
- JPY 11.99B
- Enterprise Value
- JPY 26.59B
Share Statistics
AFC-HD AMS Life Science Co., Ltd. has 14,559,699 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 14,559,699
- Owned by Insiders
- ―
- Owned by Institutions
- 0.61%
Financial Efficiency
AFC-HD AMS Life Science Co., Ltd.’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 3.55%.
- Return on Equity (ROE)
- 0.07
- Return on Assets (ROA)
- 0.02
- Return on Invested Capital (ROIC)
- 3.55%
- Return on Capital Employed (ROCE)
- 0.11
- Revenue Per Employee
- 34.05M
- Profits Per Employee
- 1.19M
- Employee Count
- 1,008
- Asset Turnover
- 0.70
- Inventory Turnover
- 2.96
Valuation Ratios
The current PE Ratio of AFC-HD AMS Life Science Co., Ltd. is 10.17. AFC-HD AMS Life Science Co., Ltd.’s PEG ratio is -0.52.
- PE Ratio
- 10.17
- PS Ratio
- 0.36
- PB Ratio
- 0.82
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- -0.52
Income Statement
In the last 12 months, AFC-HD AMS Life Science Co., Ltd. had revenue of 34.32B and earned 1.20B in profits. Earnings per share was 82.89.
- Revenue
- 34.32B
- Gross Profit
- 11.65B
- Operating Income
- 2.45B
- Pretax Income
- 1.97B
- Net Income
- 1.20B
- EBITDA
- 3.92B
- Earnings Per Share (EPS)
- 82.89
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
AFC-HD AMS Life Science Co., Ltd. pays an annual dividend of JPY 18.00, resulting in a dividend yield of 4.76%
- Dividend Per Share
- JPY 18.00
- Dividend Yield
- 4.76%
- Payout Ratio
- 33.02%
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 9.00%
Stock Price Statistics
- Beta
- 0.30
- 52-Week Price Change
- -1.87%
- 50-Day Moving Average
- 853.84
- 200-Day Moving Average
- 847.76
- Relative Strength Index (RSI)
- 45.23
- Average Volume (3m)
- 27.51K
Important Dates
AFC-HD AMS Life Science Co., Ltd. upcoming earnings date is Jan 08, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 15, 2026
- Next Earnings Date
- Jan 08, 2027
- Ex-Dividend Date
- Aug 28, 2025
Financial Position
AFC-HD AMS Life Science Co., Ltd. as a current ratio of 0.84, with Debt / Equity ratio of 144.46%
- Current Ratio
- 0.84
- Quick Ratio
- 0.55
- Debt to Market Cap
- 1.85
- Net Debt to EBITDA
- 3.48
- Interest Coverage Ratio
- 9.18
Taxes
In the past 12 months, AFC-HD AMS Life Science Co., Ltd. has paid 768.28M in taxes.
- Income Tax
- 768.28M
- Effective Tax Rate
- 0.39
Enterprise Valuation
AFC-HD AMS Life Science Co., Ltd. EV to EBITDA ratio is 6.53, with an EV/FCF ratio of 0.00.
- EV to Sales
- 0.76
- EV to EBITDA
- 6.53
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
AFC-HD AMS Life Science Co., Ltd. has JPY 9.76B in cash and marketable securities with JPY 23.41B in debt, giving a net cash position of -JPY 13.65B billion.
- Cash & Marketable Securities
- JPY 9.76B
- Total Debt
- JPY 23.41B
- Net Cash
- -JPY 13.65B
- Net Cash Per Share
- -JPY 937.38
- Tangible Book Value Per Share
- JPY 947.32
Margins
Gross margin is 33.95%, with operating margin of 7.15%, and net profit margin of 3.49%.
- Gross Margin
- 33.95%
- Operating Margin
- 7.15%
- Pretax Margin
- 5.74%
- Net Profit Margin
- 3.49%
- EBITDA Margin
- 11.59%
- EBIT Margin
- 7.30%
Analyst Forecast
The average price target for AFC-HD AMS Life Science Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 5.11%
- EPS Growth Forecast
- -19.41%
Scores
- Smart Score
- ―
- AI Score
- 56
